Richard C. Christopher
Director of Finance/CFO bei INVIVO THERAPEUTICS HOLDINGS CORP.
Vermögen: 46 $ am 31.03.2024
Profil
Richard C.
Christopher is currently the Chief Financial Officer & Treasurer at Invivo Therapeutics Holdings Corp.
He previously worked as the Chief Financial Officer & Vice President-Finance at DUSA Pharmaceuticals, Inc. from 2000 to 2013, Manager-North American Cost Accounting at W.
R.
Grace & Co.-Conn.
in 2000, CFO, Secretary, Treasurer & Executive VP at iCAD, Inc. from 2016 to 2019, and Chief Operating & Financial Officer at Caliber Imaging & Diagnostics, Inc. from 2015 to 2016.
Mr. Christopher received his undergraduate degree from Bentley University and his graduate degree from Suffolk University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.11.2023 | 210 ( 0,01% ) | 46 $ | 31.03.2024 |
Aktive Positionen von Richard C. Christopher
| Unternehmen | Position | Beginn |
|---|---|---|
| INVIVO THERAPEUTICS HOLDINGS CORP. | Director of Finance/CFO | 14.01.2019 |
Ehemalige bekannte Positionen von Richard C. Christopher
| Unternehmen | Position | Ende |
|---|---|---|
| ICAD, INC. | Director of Finance/CFO | 11.01.2019 |
| CALIBER IMAGING & DIAGNOSTICS, INC. | Director of Finance/CFO | 01.12.2016 |
DUSA Pharmaceuticals, Inc.
 DUSA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company, which develops and markets Levulan Photodynamic Therapy technology platform for the prevention and treatment of dermatological skin conditions. Its products include levulan kerastick, BLU-U and clindareach. The company was founded by D. Geoffrey Shulman on February 21, 1991 and is headquartered in Wilmington, MA. | Director of Finance/CFO | 01.04.2013 |
| W. R. GRACE & CO. | Comptroller/Controller/Auditor | 01.12.2000 |
Ausbildung von Richard C. Christopher
| Bentley University | Undergraduate Degree |
| Suffolk University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ICAD, INC. | Health Technology |
| CALIBER IMAGING & DIAGNOSTICS, INC. | Health Technology |
| INVIVO THERAPEUTICS HOLDINGS CORP. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
DUSA Pharmaceuticals, Inc.
DUSA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company, which develops and markets Levulan Photodynamic Therapy technology platform for the prevention and treatment of dermatological skin conditions. Its products include levulan kerastick, BLU-U and clindareach. The company was founded by D. Geoffrey Shulman on February 21, 1991 and is headquartered in Wilmington, MA. | Health Technology |
W. R. Grace & Co.-Conn.
 W. R. Grace & Co.-Conn. Chemicals: Major DiversifiedProcess Industries W.R. Grace & Co. engages in the production and sale of chemicals and materials. It operates through the Grace Catalysts Technologies and Grace Materials Technologies segments. The Grace Catalysts Technologies segment includes catalysts and related products and technologies used in refining, petrochemical and other chemical manufacturing applications. The Grace Materials Technologies segment consists of specialty materials, including silica-based and silica-alumina-based materials, used in coatings, consumer, industrial, and pharmaceutical applications. The firm specializes in chemical processing, coatings and inks, food and beverage, general industrial, nutraceutical, personal care, pharma, and plastics industries. The company was founded by William Russell Grace in 1854 and is headquartered in Columbia, MD. | Process Industries |
